Tristel plc (LON:TSTL - Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 440.27 ($5.71) and traded as low as GBX 420 ($5.45). Tristel shares last traded at GBX 420 ($5.45), with a volume of 21,774 shares trading hands.
Tristel Trading Up 1.2 %
The business has a 50-day moving average price of GBX 409.63 and a two-hundred day moving average price of GBX 440.27. The company has a market cap of £200.13 million, a P/E ratio of 3,230.77 and a beta of 0.23. The company has a quick ratio of 3.83, a current ratio of 4.92 and a debt-to-equity ratio of 19.12.
Tristel Increases Dividend
The firm also recently announced a dividend, which will be paid on Friday, December 20th. Shareholders of record on Thursday, November 28th will be given a dividend of GBX 8.28 ($0.11) per share. The ex-dividend date is Thursday, November 28th. This is an increase from Tristel's previous dividend of $5.24. This represents a yield of 2.1%. Tristel's dividend payout ratio is presently 10,000.00%.
Insider Activity
In other Tristel news, insider Elizabeth Dixon sold 50,000 shares of Tristel stock in a transaction on Thursday, September 19th. The shares were sold at an average price of GBX 397 ($5.15), for a total transaction of £198,500 ($257,424.46). Insiders own 4.89% of the company's stock.
About Tristel
(
Get Free Report)
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Featured Stories
Before you consider Tristel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.
While Tristel currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
